{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:08:35Z","timestamp":1789873715990,"version":"4.0.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001590","name":"Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001590","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.drugalcdep.2025.112669","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T13:44:10Z","timestamp":1743947050000},"page":"112669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Harms associated with prescription drug misuse in Ireland: A national observational study of trends in treatment demand, non-fatal intentional drug overdoses and drug related deaths 2010\u20132020"],"prefix":"10.1016","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5842-6747","authenticated-orcid":false,"given":"Louise","family":"Durand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Arensman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1201-7136","authenticated-orcid":false,"given":"Paul","family":"Corcoran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4635-6673","authenticated-orcid":false,"given":"Suzi","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3395-3831","authenticated-orcid":false,"given":"Eamon","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e1inne","family":"Cousins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112669_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/ADM.0000000000000350","article-title":"A review of alprazolam use, misuse, and withdrawal","volume":"12","author":"Ait-Daoud","year":"2018","journal-title":"J. Addict. Med."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112669_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/FTD.0000000000000789","article-title":"Is Europe facing an emerging opioid crisis comparable to the U.S.?","volume":"43","author":"van Amsterdam","year":"2021","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.drugalcdep.2025.112669_bib3","article-title":"Trends in gabapentinoid prescribing in UK primary care using the clinical practice research datalink: an observational study","volume":"27","author":"Ashworth","year":"2023","journal-title":"Lancet Reg. Health Eur."},{"key":"10.1016\/j.drugalcdep.2025.112669_bib4","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1097\/ADM.0000000000000606","article-title":"Mortality Among People With Opioid Use Disorder: A Systematic Review and Meta-analysis","volume":"14","author":"Bahji","year":"2020","journal-title":"J. Addict. Med."},{"issue":"10","key":"10.1016\/j.drugalcdep.2025.112669_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001885","article-title":"The reporting of studies conducted using observational routinely-collected health data (RECORD) statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med."},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112669_bib6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/eurpub\/ckab082","article-title":"The impact of guidance on the supply of codeine-containing products on their use in intentional drug overdose","volume":"31","author":"Birchall","year":"2021","journal-title":"Eur. J. Public Health"},{"issue":"9","key":"10.1016\/j.drugalcdep.2025.112669_bib7","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/pds.4230","article-title":"Law enforcement-derived data on gabapentin diversion and misuse, 2002-2015: diversion rates and qualitative research findings","volume":"26","author":"Buttram","year":"2017","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"6","key":"10.1016\/j.drugalcdep.2025.112669_bib8","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00228-020-03063-z","article-title":"Impact of changes in controlled drugs legislation on benzodiazepine receptor agonist prescribing in Ireland: a repeated cross-sectional study","volume":"77","author":"Cadogan","year":"2021","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.drugalcdep.2025.112669_bib9","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/bcp.13570","article-title":"Benzodiazepine and Z-drug prescribing in Ireland: analysis of national prescribing trends from 2005 to 2015","volume":"84","author":"Cadogan","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2025.112669_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11845-020-02502-1","article-title":"ADHD stimulant medication misuse and considerations for current prescribing practice: a literature review","volume":"191","author":"Carolan","year":"2021","journal-title":"Ir. J. Med. Sci. (1971 -)"},{"issue":"5","key":"10.1016\/j.drugalcdep.2025.112669_bib11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000337028","article-title":"Misuse of medicines in the European Union: a systematic review of the literature","volume":"18","author":"Casati","year":"2012","journal-title":"Eur. Addict. Res."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112669_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/dar.12893","article-title":"Non-medical use of pharmaceutical opioids with and without other illicit substances in Australia: Prevalence and correlates","volume":"38","author":"Chan","year":"2019","journal-title":"Drug Alcohol Rev."},{"issue":"9","key":"10.1016\/j.drugalcdep.2025.112669_bib13","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1177\/02698811221104065","article-title":"Alprazolam-related deaths in Scotland, 2004-2020","volume":"36","author":"Corkery","year":"2022","journal-title":"J. Psychopharmacol. (Oxf., Engl. )"},{"key":"10.1016\/j.drugalcdep.2025.112669_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/add.13087","article-title":"Risk of mortality on and off methadone substitution treatment in primary care: a national cohort study","volume":"111","author":"Cousins","year":"2016","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112669_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-069665","article-title":"Prescription drugs with potential for misuse: protocol for a multi-indicator analysis of supply, detection and the associated health burden in Ireland between 2010 and 2020","volume":"13","author":"Cousins","year":"2023","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112669_bib16","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/bcp.14797","article-title":"Nonmedical use of prescription drugs","volume":"87","author":"Cremers","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112669_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40261-017-0616-y","article-title":"Intentional Drug Overdose Involving Pregabalin and Gabapentin: Findings from the National Self-Harm Registry Ireland, 2007-2015","volume":"38","author":"Daly","year":"2018","journal-title":"Clin. Drug Investig."},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112669_bib18","first-page":"681","article-title":"Frequently used drug types and alcohol involvement in intentional drug overdoses in Ireland: a national registry study","volume":"28","author":"Daly","year":"2018","journal-title":"Eur. J. Public Health"},{"issue":"6","key":"10.1016\/j.drugalcdep.2025.112669_bib19","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/bcp.13892","article-title":"Patterns of gabapentin and pregabalin use and misuse: Results of a population-based cohort study in France","volume":"85","author":"Driot","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2025.112669_bib20","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1111\/add.15004","article-title":"Do interruptions to the continuity of methadone maintenance treatment in specialist addiction settings increase the risk of drug-related poisoning deaths? A retrospective cohort study","volume":"115","author":"Durand","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2025.112669_bib21","article-title":"Gabapentinoids in Ireland 2010 to 2020: An observational study of trends in gabapentinoid prescribing, law enforcement drug seizures and postmortem toxicology","author":"Durand","year":"2023","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2025.112669_bib22","series-title":"Treatment demand indicator (TDI) standard protocol 3.0: Guidelines for reporting data on people entering drug treatment in European countries","volume":"9","author":"EMCDDA","year":"2012"},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112669_bib23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s40265-017-0700-x","article-title":"Abuse and Misuse of Pregabalin and Gabapentin","volume":"77","author":"Evoy","year":"2017","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112669_bib24","first-page":"S89","article-title":"Gabapentinoid Pharmacology in the Context of Emerging Misuse Liability","volume":"61","author":"Evoy","year":"2021","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112669_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40265-020-01432-7","article-title":"Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update","volume":"81","author":"Evoy","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.drugalcdep.2025.112669_bib26","series-title":"Charting the fourth wave: Geographic, temporal, race\/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010-2021","author":"Friedman","year":"2023"},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112669_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010538","article-title":"Epidemiology and trends in non-fatal self-harm in three centres in England, 2000-2012: findings from the Multicentre Study of Self-harm in England","volume":"6","author":"Geulayov","year":"2016","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112669_bib28","doi-asserted-by":"crossref","first-page":"e548","DOI":"10.4088\/JCP.11m07209","article-title":"Prescribed medication availability and deliberate self-poisoning: a longitudinal study","volume":"73","author":"Gjelsvik","year":"2012","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.drugalcdep.2025.112669_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098086","article-title":"Change in access to prescribed medication following an episode of deliberate self-poisoning: a multilevel approach","volume":"9","author":"Gjelsvik","year":"2014","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112669_bib30","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1360-0443.2011.03369.x","article-title":"Addiction research centres and the nurturing of creativity. Monitoring the European drug situation: the ongoing challenge for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)","volume":"107","author":"Griffiths","year":"2012","journal-title":"Addict. (Abingdon, Engl. )"},{"issue":"12","key":"10.1016\/j.drugalcdep.2025.112669_bib31","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s40264-020-00985-6","article-title":"Current Evidence on Abuse and Misuse of Gabapentinoids","volume":"43","author":"H\u00e4gg","year":"2020","journal-title":"Drug Saf."},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112669_bib32","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/add.14014","article-title":"Non-medical use of psychoactive prescription drugs is associated with fatal poisoning","volume":"113","author":"Haukka","year":"2018","journal-title":"Addict. (Abingdon, Engl. )"},{"key":"10.1016\/j.drugalcdep.2025.112669_bib33","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1111\/bph.14219","article-title":"Oxycodone-induced tolerance to respiratory depression: reversal by ethanol, pregabalin and protein kinase C inhibition","volume":"175","author":"Hill","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.drugalcdep.2025.112669_bib34","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1111\/bcp.13959","article-title":"Nonmedical use of alprazolam in the UK: Results from a nationally representative survey","volume":"85","author":"Hockenhull","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112669_bib35","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/bcp.14397","article-title":"Nonmedical use of benzodiazepines and Z-drugs in the UK","volume":"87","author":"Hockenhull","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112669_bib36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2125.2004.02089.x","article-title":"Alprazolam is relatively more toxic than other benzodiazepines in overdose","volume":"58","author":"Isbister","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112669_bib37","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jamainternmed.2017.7856","article-title":"Gabapentinoid Use in the United States 2002 Through 2015","volume":"178","author":"Johansen","year":"2018","journal-title":"JAMA Intern. Med."},{"issue":"8","key":"10.1016\/j.drugalcdep.2025.112669_bib38","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1111\/bcp.15352","article-title":"Fatalities associated with gabapentinoids in England (2004-2020)","volume":"88","author":"Kalk","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2025.112669_bib39","series-title":"National Drug Treatment Reporting System 2015 \u2013 2021 drug treatment data","author":"Kelleher","year":"2022"},{"key":"10.1016\/j.drugalcdep.2025.112669_bib40","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jamapsychiatry.2019.4170","article-title":"All-Cause and Cause-Specific Mortality Among People Using Extramedical Opioids","volume":"77","author":"Larney","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2025.112669_bib41","article-title":"Mortality involving New Psychoactive Substances across Europe, 2016-2017","volume":"1","author":"L\u00f3pez-Pelayo","year":"2021","journal-title":"Emerg. Trends Drugs, Addict., Health"},{"issue":"9","key":"10.1016\/j.drugalcdep.2025.112669_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048000","article-title":"Trends in drug poisoning deaths, by sex, in Ireland: a repeated cross-sectional study from 2004 to 2017","volume":"11","author":"Lynn","year":"2021","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.drugalcdep.2025.112669_bib43","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S2215-0366(19)30331-1","article-title":"Medicines associated with dependence or withdrawal: a mixed-methods public health review and national database study in England","volume":"6","author":"Marsden","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.drugalcdep.2025.112669_bib44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.12688\/hrbopenres.13622.2","article-title":"Eligibility rates and representativeness of the General Medical Services scheme population in Ireland 2016-2021: A methodological report","volume":"5","author":"Mattsson","year":"2023","journal-title":"HRB Open Res."},{"key":"10.1016\/j.drugalcdep.2025.112669_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103512","article-title":"From the clinic to the street: the changing role of benzodiazepines in the Scottish overdose epidemic","volume":"100","author":"McAuley","year":"2022","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2025.112669_bib46","article-title":"Increased risk of non-fatal overdose associated with non-prescribed benzodiazepine use in Scotland, UK","author":"McAuley","year":"2023","journal-title":"Int. J. Drug Policy"},{"issue":"Sup 18","key":"10.1016\/j.drugalcdep.2025.112669_bib47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.15288\/jsads.2019.s18.139","article-title":"The Experience of the Treatment Demand Indicator in Europe: A Common Monitoring Tool Across 30 Countries","author":"Montanari","year":"2019","journal-title":"J. Stud. Alcohol Drugs Suppl."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112669_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.899","article-title":"Opioid and analgesic utilization in Ireland in 2000 and 2015: A repeated cross-sectional study","volume":"10","author":"Moriarty","year":"2022","journal-title":"Pharmacol. Res. Perspect."},{"issue":"7","key":"10.1016\/j.drugalcdep.2025.112669_bib49","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jat\/bkz036","article-title":"Misuse and Mortality Related to Gabapentin and Pregabalin are Being Under-Estimated: A Two-Year Post-Mortem Population Study","volume":"43","author":"Nahar","year":"2019","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2025.112669_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/pds.5247","article-title":"Trends in strong opioid prescribing in Ireland: A repeated cross-sectional analysis of a national pharmacy claims database between 2010 and 2019","author":"Norris","year":"2021","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.drugalcdep.2025.112669_bib51","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12888-016-0909-3","article-title":"Nonmedical use of prescription drugs in the European Union","volume":"16","author":"Novak","year":"2016","journal-title":"BMC Psychiatry"},{"issue":"10","key":"10.1016\/j.drugalcdep.2025.112669_bib52","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/add.13741","article-title":"Do more robust prescription drug monitoring programs reduce prescription opioid overdose?","volume":"112","author":"Pardo","year":"2017","journal-title":"Addict. (Abingdon, Engl. )"},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112669_bib53","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2021.2219","article-title":"Is Europe facing an opioid crisis like the United States? An analysis of opioid use and related adverse effects in 19 European countries between 2010 and 2018","volume":"64","author":"Pierce","year":"2021","journal-title":"Eur. Psychiatry.: J. Assoc. Eur. Psychiatr."},{"key":"10.1016\/j.drugalcdep.2025.112669_bib54","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1111\/bcp.15323","article-title":"Increase of high-risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data","volume":"88","author":"Roussin","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2025.112669_bib55","unstructured":"SAS Institute, 1999. SAS\/STAT user's guide 8."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112669_bib56","doi-asserted-by":"crossref","DOI":"10.3399\/bjgpopen20X101120","article-title":"Pregabalin prescribing patterns in Australian general practice, 2012-2018: a cross-sectional study","volume":"5","author":"Schaffer","year":"2021","journal-title":"BJGP Open"},{"issue":"7","key":"10.1016\/j.drugalcdep.2025.112669_bib57","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/17512433.2016.1178571","article-title":"The consequences of drug misuse on post-marketing surveillance","volume":"9","author":"Schifano","year":"2016","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112669_bib58","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2105\/AJPH.2017.304265","article-title":"Quantifying the Epidemic of Prescription Opioid Overdose Deaths","volume":"108","author":"Seth","year":"2018","journal-title":"Am. J. Public Health"},{"issue":"5","key":"10.1016\/j.drugalcdep.2025.112669_bib59","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/ejp.1728","article-title":"Is Europe facing an opioid epidemic: What does European monitoring data tell us?","volume":"25","author":"Seyler","year":"2021","journal-title":"Eur. J. Pain. (Lond., Engl. )"},{"key":"10.1016\/j.drugalcdep.2025.112669_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.640120","article-title":"Early Detection of Prescription Drug Abuse Using Doctor Shopping Monitoring From Claims Databases: Illustration From the Experience of the French Addictovigilance Network","volume":"12","author":"Soeiro","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"10","key":"10.1016\/j.drugalcdep.2025.112669_bib61","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1111\/add.16261","article-title":"Systematic assessment of non-medical use of prescription drugs using doctor-shopping indicators: A nation-wide, repeated cross-sectional study","volume":"118","author":"Soeiro","year":"2023","journal-title":"Addict. (Abingdon, Engl. )"},{"key":"10.1016\/j.drugalcdep.2025.112669_bib62","doi-asserted-by":"crossref","first-page":"j760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","author":"Sun","year":"2017","journal-title":"BMJ (Clin. Res. Ed. ) 356"},{"key":"10.1016\/j.drugalcdep.2025.112669_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.639780","article-title":"Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance","volume":"12","author":"Tambon","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112669_bib64","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00406-008-0839-2","article-title":"Factors associated with choice of psychotropic drugs used for intentional drug overdose","volume":"259","author":"Tournier","year":"2009","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.drugalcdep.2025.112669_bib65","article-title":"Non-Medical Use of Benzodiazepines: A Growing Threat to Public Health?","volume":"18","author":"UNODC","year":"2017"},{"issue":"10","key":"10.1016\/j.drugalcdep.2025.112669_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.drugalcdep.2025.112669_bib67","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: A systematic review","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112669_bib68","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1111\/bcp.14592","article-title":"Regional, national and international datasets: How they improve our understanding of the acute harms associated with prescription medicine misuse","volume":"87","author":"Wood","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.drugalcdep.2025.112669_bib69","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S2215-0366(16)30030-X","article-title":"Suicide prevention strategies revisited: 10-year systematic review","volume":"3","author":"Zalsman","year":"2016","journal-title":"Lancet Psychiatry"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687162500122X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687162500122X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:01:16Z","timestamp":1774530076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037687162500122X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":69,"alternative-id":["S037687162500122X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112669","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harms associated with prescription drug misuse in Ireland: A national observational study of trends in treatment demand, non-fatal intentional drug overdoses and drug related deaths 2010\u20132020","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112669","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112669"}}